Les autorités sanitaires américaines ont approuvé une mise à jour de l'étiquette avec un nouveau schéma posologique pour Kisunla, le traitement anti-amyloïde à prise mensuelle d'Eli Lilly ...

LLY's explosive growth from Mounjaro and Zepbound outpaces MRK's Keytruda-led gains, despite valuation concerns.

January was a big month for pharmaceutical stocks, with Merck(NYSE: MRK), Eli Lilly(NYSE: LLY), and Novo Nordisk(NYSE: NVO) all climbing 11%, according to data provided by S&P Global Market ...

Novo Nordisk A/S ADR (NVO-N) NYSE Add to Watchlist Create Alerts 126.99 USD +0.53 +0.42% Real-Time Last Update 04/03/24 Last Sale Cboe BZX Real-Time Volume 3,609,254 Summary Charts Profile ...

For Immediate Release Chicago, IL – July 17, 2024 – Today, Zacks Equity Research discusses Eli Lilly LLY, Novo Nordisk NVO, Merck MRK and Pfizer PFE.